(Q40147132)

English

Transcutaneous immunization with imiquimod is amplified by CD40 ligation and results in sustained cytotoxic T-lymphocyte activation and tumor protection

scientific article published on February 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Transcutaneous immunization with imiquimod is amplified by CD40 ligation and results in sustained cytotoxic T-lymphocyte activation and tumor protection (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

author name string

Tobias Warger

1

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Gerd Rechtsteiner

2

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Beate Schmid

3

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Philipp Osterloh

4

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Hansjörg Schild

5

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Markus P Radsak

6

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

publication date

1 February 2007

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Clinical Reviews in Allergy & Immunology

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

57-66

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

https://scigraph.springernature.com/pub.10.1007/bf02686082

0 references

Cutting edge: priming of CTL by transcutaneous peptide immunization with imiquimod

1 reference

https://api.crossref.org/works/10.1007%2FBF02686082

21 January 2018

Transcutaneous immunization induces mucosal CTLs and protective immunity by migration of primed skin dendritic cells

1 reference

https://api.crossref.org/works/10.1007%2FBF02686082

21 January 2018

Imiquimod and resiquimod in a mouse model: adjuvants for DNA vaccination by particle-mediated immunotherapeutic delivery

1 reference

https://pubmed.ncbi.nlm.nih.gov/17426361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of CD40 ligand in costimulation and T-cell activation

1 reference

https://pubmed.ncbi.nlm.nih.gov/17426361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help

1 reference

https://pubmed.ncbi.nlm.nih.gov/17426361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transcutaneous immunization: a human vaccine delivery strategy using a patch

1 reference

https://pubmed.ncbi.nlm.nih.gov/17426361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effector and memory T-cell differentiation: implications for vaccine development

1 reference

https://pubmed.ncbi.nlm.nih.gov/17426361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The danger model: a renewed sense of self

1 reference

https://pubmed.ncbi.nlm.nih.gov/17426361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/17426361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer immunotherapy: moving beyond current vaccines

1 reference

https://pubmed.ncbi.nlm.nih.gov/17426361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined TLR and CD40 triggering induces potent CD8+ T cell expansion with variable dependence on type I IFN

1 reference

https://pubmed.ncbi.nlm.nih.gov/17426361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of models in understanding CD8+ T-cell memory

1 reference

https://pubmed.ncbi.nlm.nih.gov/17426361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD40 AND CD154 IN CELL-MEDIATED IMMUNITY

1 reference

https://pubmed.ncbi.nlm.nih.gov/17426361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Progress in human tumour immunology and immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17426361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell

1 reference

https://pubmed.ncbi.nlm.nih.gov/17426361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imiquimod, a topical immune response modifier, induces migration of Langerhans cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/17426361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transcutaneous immunization with cytotoxic T-cell peptide epitopes provides effective antitumor immunity in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/17426361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanisms of tumor evasion.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17426361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17426361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions

1 reference

https://pubmed.ncbi.nlm.nih.gov/17426361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adoptive-cell-transfer therapy for the treatment of patients with cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17426361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Murine T cell subsets and interleukins: relationships between cytotoxic T cells, helper T cells and accessory cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/17426361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The impact of imiquimod, a Toll-like receptor-7 ligand (TLR7L), on the immunogenicity of melanoma peptide vaccination with adjuvant Flt3 ligand

1 reference

https://pubmed.ncbi.nlm.nih.gov/17426361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/17426361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cooperation between CD4+ and CD8+ T cells: when, where, and how.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17426361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Massive expansion of antigen-specific CD8+ T cells during an acute virus infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/17426361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD40–CD40Ligand interactions and their role in cytotoxic T lymphocyte priming and anti-tumor immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/17426361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Translating innate immunity into immunological memory: implications for vaccine development

1 reference

https://pubmed.ncbi.nlm.nih.gov/17426361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17426361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antitumor immunization with a minimal peptide epitope (G9-209-2M) leads to a functionally heterogeneous CTL response

1 reference

https://pubmed.ncbi.nlm.nih.gov/17426361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF02686082

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40147132&oldid=2141851008"